INVO Fertility Files 8-K on Equity Sale
Ticker: IVF · Form: 8-K · Filed: Oct 10, 2025 · CIK: 1417926
Sentiment: neutral
Topics: equity-sale, unregistered-securities, filing
TL;DR
INVO Fertility sold unregistered equity, potentially diluting shares.
AI Summary
On October 6, 2025, INVO Fertility, Inc. filed an 8-K report detailing the unregistered sale of equity securities. The company, formerly known as NAYA Biosciences, Inc., is incorporated in Nevada and headquartered in Sarasota, Florida.
Why It Matters
This filing indicates INVO Fertility has issued new equity, which could impact existing shareholders through dilution or signal a need for capital.
Risk Assessment
Risk Level: medium — Unregistered sales of equity can sometimes signal financial distress or lead to dilution for existing shareholders.
Key Players & Entities
- INVO Fertility, Inc. (company) — Registrant
- NAYA Biosciences, Inc. (company) — Former company name
- October 6, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- Sarasota, FL (location) — Principal executive offices
FAQ
What type of equity securities were sold?
The filing states 'Unregistered Sales of Equity Securities' but does not specify the exact type of securities in the provided text.
Were these securities sold to accredited investors?
The filing mentions 'Unregistered Sales of Equity Securities,' which typically implies a sale under an exemption from registration, often to accredited investors, but the specific details are not in this excerpt.
What was the purpose of this unregistered sale of equity?
The provided text of the 8-K filing does not disclose the specific purpose for the unregistered sale of equity securities.
When was the company formerly known as NAYA Biosciences, Inc.?
The company was formerly known as NAYA Biosciences, Inc. prior to October 22, 2024, as indicated by the 'DATE OF NAME CHANGE: 20241022'.
What is INVO Fertility, Inc.'s SIC code?
INVO Fertility, Inc.'s Standard Industrial Classification (SIC) code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Stats: 586 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2025-10-10 16:05:35
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value IVF The Nasdaq Stock Mark
- $200,000 — rred, with an aggregate stated value of $200,000, for $200,000 in cash. As a result of t
- $0.6643 — price on the C-2 Preferred adjusted to $0.6643 per share. The C-2 Preferred issued pur
Filing Documents
- form8-k.htm (8-K) — 35KB
- 0001493152-25-017752.txt ( ) — 195KB
- ivf-20251006.xsd (EX-101.SCH) — 3KB
- ivf-20251006_lab.xml (EX-101.LAB) — 33KB
- ivf-20251006_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 10, 2025 INVO FERTILITY, INC. /s/ Steven Shum Steven Shum Chief Executive Officer